Deep brain stimulation in Parkinson's disease: A multicentric, long-term, observational pilot study

[1]  B. Lau,et al.  Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patients. , 2019, Parkinsonism & related disorders.

[2]  F. Weaver,et al.  Survival in patients with Parkinson's disease after deep brain stimulation or medical management , 2017, Movement disorders : official journal of the Movement Disorder Society.

[3]  R. Sakakibara,et al.  A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders , 2016, Neurourology and urodynamics.

[4]  R. Dmochowski,et al.  The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's Disease , 2016, Neuromodulation : journal of the International Neuromodulation Society.

[5]  G. Fink,et al.  Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease , 2016, Brain Stimulation.

[6]  I. Dalen,et al.  The long‐term development of non‐motor problems after STN‐DBS , 2015, Acta neurologica Scandinavica.

[7]  E. Dietrichs,et al.  Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. , 2015, Parkinsonism & related disorders.

[8]  Sara Marceglia,et al.  WebBioBank: A new platform for integrating clinical forms and shared neurosignal analyses to support multi-centre studies in Parkinson's Disease , 2014, J. Biomed. Informatics.

[9]  E. Dietrichs,et al.  Progression and survival in Parkinson's disease with subthalamic nucleus stimulation , 2014, Acta neurologica Scandinavica.

[10]  S. Tisch,et al.  Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  Young Eun Kim,et al.  Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease , 2014, Journal of Neurology.

[12]  J. Massano,et al.  Long-Term Mortality Analysis in Parkinson's Disease Treated with Deep Brain Stimulation , 2014, Parkinson's disease.

[13]  C. Clarke,et al.  Reasons for Parkinson's disease admissions in a large inner city hospital. , 2014, Parkinsonism & related disorders.

[14]  B. Bloem,et al.  High rates and the risk factors for emergency room visits and hospitalization in Parkinson's disease. , 2013, Parkinsonism & related disorders.

[15]  H. Pall,et al.  Deep brain stimulation improves survival in severe Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  Efficacy of deep brain stimulation of the subthalamic nucleus on autonomic dysfunction in patients with Parkinson's disease. , 2013, Folia medica Cracoviensia.

[17]  Nir Giladi,et al.  Falls in Parkinson disease: analysis of a large cross-sectional cohort. , 2013, Journal of Parkinson's disease.

[18]  K. Winge,et al.  Bladder dysfunction in advanced Parkinson's disease , 2012, Neurourology and urodynamics.

[19]  J. Massano,et al.  Deep Brain Stimulation and Cognitive Decline in Parkinson’s Disease: A Clinical Review , 2012, Front. Neur..

[20]  A. Lang,et al.  Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. , 2011, Archives of neurology.

[21]  G. K. Røste,et al.  Long‐term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation , 2011, Movement disorders : official journal of the Movement Disorder Society.

[22]  Aristide Merola,et al.  Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. , 2011, Brain : a journal of neurology.

[23]  S. Rehncrona,et al.  Fear of falling and falls in people with Parkinson’s disease treated with deep brain stimulation in the subthalamic nuclei , 2011, Acta neurologica Scandinavica.

[24]  Angie A. Kehagia,et al.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.

[25]  G. Alves,et al.  What predicts mortality in Parkinson disease? , 2010, Neurology.

[26]  A. Bentivoglio,et al.  Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. , 2010, Brain : a journal of neurology.

[27]  R. Walker,et al.  The cause of death in idiopathic Parkinson's disease. , 2010, Parkinsonism & related disorders.

[28]  Keith Wheatley,et al.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial , 2010, The Lancet Neurology.

[29]  Marco Sassi,et al.  Deep brain stimulation and cognitive functions in Parkinson's disease: A three‐year controlled study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[30]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.

[31]  Grant D. Huang,et al.  Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. , 2009, JAMA.

[32]  S. Rehncrona,et al.  The effects of high frequency subthalamic stimulation on balance performance and fear of falling in patients with Parkinson's disease , 2009, Journal of NeuroEngineering and Rehabilitation.

[33]  Marten Munneke,et al.  Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[34]  Adrian Danek,et al.  Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study , 2008, The Lancet Neurology.

[35]  J. Jankovic,et al.  Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[36]  Ann Ashburn,et al.  A meta‐analysis of six prospective studies of falling in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[37]  J. Villemure,et al.  Long‐term cognitive profile and incidence of dementia after STN‐DBS in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[38]  Anette Schrag,et al.  Estimated life expectancy of Parkinson’s patients compared with the UK population , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[39]  A. Bentivoglio,et al.  Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  Thomas D Parsons,et al.  Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis , 2006, The Lancet Neurology.

[41]  J. Villemure,et al.  Absence of cholinergic deficits in “pure” vascular dementia , 2005, Neurology.

[42]  J. Volkmann,et al.  Effect of subthalamic deep brain stimulation on the function of the urinary bladder , 2004, Annals of neurology.

[43]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.